CompletedPhase 4

Enteroadsorbent Polymethylsiloxane vs Probiotic Lactobacillus Reuteri in the Treatment of Rotaviral Gastroenteritis

Croatia130 participantsStarted 2013-01-01

Plain-language summary

This study evaluates a new drug, new enteroadsorbent polymethylsiloxane (Enterosgel) in the treatment of rotavirus gastroenteritis in children. Half of the participants received a new drug, polymethylsiloxane and half of the participants received standard treatment - probiotic L. reuteri (BioGaia).

Who can participate

Age range6 Months – 3 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. age 6-36 months
✓. proven rotavirus gastroenteritis
✓. symptom duration less than 48 hours
✓. informed consent of the parents/caregivers

Exclusion criteria

✕. rotavirus vaccination
✕. rotavirus infection in a patient's history
✕. severe acute or chronic illness with possible influence on rotavirus gastroenteritis outcome

What they're measuring

Gastroenteritis symptoms duration.

Timeframe: 1-8 days.

Trial details

NCT IDNCT04116307

SponsorUniversity Hospital for Infectious Diseases, Croatia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-05-31

View on ClinicalTrials.gov More Rotavirus Gastroenteritis trials